[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354229-105":59,"doc-detail-354229-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cdk1-phosphorylates-kat8-at-ser348-to-stabilize-the-msl-complex-and-promote-h4k16-acetylation-in-non-small-cell-lung-cancer","CDK1 Phosphorylates KAT8 at Ser348 to Stabilize the MSL Complex and Promote H4K16 Acetylation in Non-Small Cell Lung Cancer","","Cyclin-dependent kinase 1 (CDK1) is frequently upregulated across cancers and is central to cell-cycle control, yet its direct regulation of the histone acetyltransferase KAT8 in non-small cell lung cancer (NSCLC) has been unclear. This study shows CDK1 directly phosphorylates KAT8 at S348 and T418, with S348 as the dominant site. CDK1-driven phosphorylation enhances KAT8–MSL1 binding, stabilizes the MSL complex, and promotes H4K16 acetylation. The KAT8-S348A mutant impairs MSL assembly, reduces H4K16 acetylation, and suppresses NSCLC proliferation in vitro and in vivo. CDK1 inhibition with RO-3306 decreases KAT8 phosphorylation and tumor growth, partly rescued by wild-type KAT8.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cdk1-phosphorylates-kat8-at-ser348-to-stabilize-the-msl-complex-and-promote-h4k16-acetylation-in-non-small-cell-lung-cancer/354229/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cdk1-phosphorylates-kat8-at-ser348-to-stabilize-the-msl-complex-and-promote-h4k16-acetylation-in-non-small-cell-lung-cancer/354229.png","ImageObject",300,407,{"name":92,"@type":93},"Pentious","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What phosphorylation sites does CDK1 target on KAT8 in NSCLC?","Question",{"text":112,"@type":113},"CDK1 phosphorylates KAT8 at serine 348 (S348) and threonine 418 (T418), with S348 identified as the dominant regulatory site.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does CDK1-mediated KAT8 phosphorylation affect the MSL complex and histone acetylation?",{"text":117,"@type":113},"Phosphorylation, particularly at S348, strengthens the KAT8–MSL1 interaction, stabilizes the MSL complex, and promotes KAT8-dependent acetylation of histone H4 at lysine 16 (H4K16).",{"name":119,"@type":110,"acceptedAnswer":120},"What is the impact of blocking CDK1 or expressing the KAT8-S348A mutant?",{"text":121,"@type":113},"The phosphorylation-deficient KAT8-S348A mutant reduces H4K16 acetylation, impairs MSL complex assembly, and suppresses NSCLC cell proliferation in vitro and in vivo. Pharmacological inhibition with RO-3306 similarly suppresses KAT8 phosphorylation and H4K16 acetylation, inhibiting tumor growth, with partial rescue by wild-type KAT8 but not the S348A mutant.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},354229,1790211544,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},1374404730887,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Article  \nCDK1 Phosphorylates KAT8 at Ser348 to Stabilize the MSL Complex and Promote H4K16 Acetylation in Non-Small Cell Lung Cancer  \nJinmeng Chu, Qingzhi Zhao, Hui Ye, Meixu Li, Yizhen Wang, Tiantian Xu, Yong Cai and Jingji Jin *  \nAcademic Editors: Anand Singh and Sudheer Kumar Gara  \nReceived: 18 April 2026  \nRevised: 6 May 2026  \nAccepted: 13 May 2026  \nPublished: 14 May 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \nSchool of Life Sciences, Jilin University, Changchun 130012, China; [chujm21@mails.jlu.edu.cn](chujm21@mails.jlu.edu.cn) (J.C.);  \n[zhaoqz23@mails.jlu.edu.cn](zhaoqz23@mails.jlu.edu.cn) (Q.Z.); [yehuiswx@163.com](yehuiswx@163.com) (H.Y.); [mx953665@126.com](mx953665@126.com) (M.L.);  \n[yizhen23@mails.jlu.edu.cn](yizhen23@mails.jlu.edu.cn) (Y.W.); [xutt23@mails.jlu.edu.cn](xutt23@mails.jlu.edu.cn) (T.X.); [caiyong62@jlu.edu.cn](caiyong62@jlu.edu.cn) (Y.C.)  \n* [Correspondence: jjjin@jlu.edu.cn](Correspondence: jjjin@jlu.edu.cn)  \nHighlights  \nWhat are the main findings?  \n• CDK1 directly phosphorylates KAT8 at Ser348 and Thr418, with Ser348 serving as the dominant regulatory site.  \n• CDK1-mediated phosphorylation, particularly at Ser348, stabilizes the MSL complex by enhancing KAT8-MSL1 interaction and promotes H4K16 acetylation.  \nWhat are the implications of the main findings?  \n• The phosphorylation-deficient KAT8-S348A mutant impairs H4K16 acetylation and suppresses NSCLC cell proliferation both in vitro and in vivo.  \n• Pharmacological inhibition ofCDK1 with RO-3306 reduces KAT8 phosphorylation and tumor growth, identifying the CDK1–KAT8 axis as a potential therapeutic target in lung cancer.  \nAbstract  \nCyclin-dependent kinase 1 (CDK1) is frequently upregulated in multiple cancers and plays a central role in cell cycle progression and tumorigenesis. However, whether CDK1 directly regulates the histone acetyltransferase KAT8 (also known as MOF) in non-small cell lung cancer (NSCLC) remains unclear. Here, we identify CDK1 as a kinase that directly interacts with and phosphorylates KAT8 at serine 348 (S348) and threonine 418 (T418) . Mechanistically, CDK1-mediated phosphorylation, particularly at S348, enhances the interaction between KAT8 and MSL1, thereby stabilizing the MSL complex and promoting KAT8-dependent acetylation of histone H4 at lysine 16 (H4K16) . Functionally, the phosphorylation-deficient mutant KAT8-S348A exhibits impaired MSL complex assembly, reduced H4K16 acetylation, and decreased NSCLC cell proliferation both in vitro and in vivo. Pharmacological inhibition of CDK1 using RO-3306 suppresses KAT8 phosphorylation and H4K16 acetylation, leading to significant tumor growth inhibition. Notably, this effect is partially rescued by re-expression of wild-type KAT8 but not by the S348A mutant, supporting a phosphorylation-dependent mechanism. Collectively, these findings define a CDK1–KAT8 signaling axis that promotes NSCLC proliferation through epigenetic regulation and suggest that targeting CDK1-dependent KAT8 phosphorylation may represent a potential therapeutic strategy for lung cancer.  \nKeywords: KAT8; CDK1; phosphorylation; non-small cell lung cancer; drug-resistance; cell proliferation  \n1. Introduction  \nLung cancer remains one of the most lethal malignancies worldwide and is broadly classified into non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) [1] . Surgical resection is the preferred treatment for patients with early-stage NSCLC, whereas advanced disease requires a comprehensive therapeutic strategy guided by histopathological subtype, tumor stage, molecular alterations, and patient condition. In this context, chemotherapy, radiotherapy, and molecularly targeted therapies, and immune checkpoint inhibitors constitute the principal treatment modalities [2] . In addition, emerging approaches, includ","cbCaichC9kciIdtj","https://ap.wps.com/l/cbCaichC9kciIdtj","pdf",24734405,"English","# Introduction\n# CDK1–KAT8 Mechanism and Phosphorylation Sites\n# KAT8 Mutant Effects on MSL Complex and H4K16 Acetylation\n# CDK1 Inhibition and Tumor Growth Outcomes","[{\"question\":\"What phosphorylation sites does CDK1 target on KAT8 in NSCLC?\",\"answer\":\"CDK1 phosphorylates KAT8 at serine 348 (S348) and threonine 418 (T418), with S348 identified as the dominant regulatory site.\"},{\"question\":\"How does CDK1-mediated KAT8 phosphorylation affect the MSL complex and histone acetylation?\",\"answer\":\"Phosphorylation, particularly at S348, strengthens the KAT8–MSL1 interaction, stabilizes the MSL complex, and promotes KAT8-dependent acetylation of histone H4 at lysine 16 (H4K16).\"},{\"question\":\"What is the impact of blocking CDK1 or expressing the KAT8-S348A mutant?\",\"answer\":\"The phosphorylation-deficient KAT8-S348A mutant reduces H4K16 acetylation, impairs MSL complex assembly, and suppresses NSCLC cell proliferation in vitro and in vivo. Pharmacological inhibition with RO-3306 similarly suppresses KAT8 phosphorylation and H4K16 acetylation, inhibiting tumor growth, with partial rescue by wild-type KAT8 but not the S348A mutant.\"}]","CDK1 Phosphorylates KAT8 at Ser348 to Stabilize the MSL Complex and Promote H4K16 Acetylation in Non-Small Cell Lung Cancer | PDF",1790109641,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e6b882fcefdfdfb997fe1ccdfc9b7fd5.webp",983,1390,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7d28f1b261edff1d536e91fe9cd4dd69.webp",982,1388,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d81eca8e16c357380fcbeb18c1b0b9f0.webp",981,1387,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3ec63c54085723d74f4b70617063061e.webp",980,1385]